60 Degrees Pharmaceuticals (SXTPW) Stock: Why It's Up Today
Updated Oct 20, 2026, 4:00 PM ET · closing price
- Closed at $0.03, +32.00% vs the prior close of $0.02.
- Volume 13.32K shares, 4441.3x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SXTPW jumps 32.0% to $0.03 on 4441.3x normal volume. Closed at $0.03, +32.00% vs the prior close of $0.02. Day range $0.03–$0.03, opened at $0.05.
SXTPW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — SXTPW jumps 32.0% to $0.03 on 4441.3x normal volume
- Closed at $0.03, +32.00% vs the prior close of $0.02. Day range $0.03–$0.03, opened at $0.05.
- Volume was 13.32K shares, 4441.3x its 50-day average of 3 — unusually heavy trading.
- 52-week range $0.02–$0.03; today's close sits at 73% of that range, 9.5% below the 52-week high.
SXTPW bull case vs bear case (from the data)
- Annual revenue grew 65.5% in the latest fiscal year (SEC XBRL).
- Insiders made 16 open-market purchases in the last 12 months.
- Share count down 14.3% in a year (buybacks).
- Latest fiscal-year net income: loss of $7.37M.
- High volatility: average daily move of 32.0% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
SXTPW latest news & SEC filings
Every SEC filing by or about SXTPW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 25, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 17, 2026 · Form DEL AM — DEL AM filing
DEL AM filing
Aug 14, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $207.90K (prior year $100.93K) (+106.0% vs Jun 30, 2025)
- Net income: -$2.26M (prior year -$1.73M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.90 (prior year -$5.01) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 5, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Jul 29, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 2, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade SXTPW
- How much it moves: over the last 20 sessions the average daily move was 32.00% (largest 32.0%). That is a volatile stock.
- Liquidity: about 6.66K shares (≈$198) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.03 vs a range of $0.02–$0.03 (73% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Geoffrey S Dow bought 7,350 shares on Jun 12, 2026.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 14, 2026; 8-K Sep 8, 2026.
- Share count: 3.52M shares outstanding (Aug 14, 2026), -14.3% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SXTPW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 0.05 | 0.03 | 0.03 | 0.03 | 13.32K |
| Oct 16, 2026 | 0.05 | 0.02 | 0.02 | 0.02 | 3 |
About 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals (SXTPW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WASHINGTON, DC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1946563.
SXTPW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Geoffrey S Dow | President and CEO | Jun 15, 2026 |
| Eric Francois | Director | May 19, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Geoffrey S Dow | President and CEO | Jun 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 12, 2026 | Geoffrey S Dow | Buy | 7,350 | $1.38 |
| Jun 12, 2026 | Geoffrey S Dow | Buy | 7,350 | $1.38 |
| Jun 12, 2026 | Geoffrey S Dow | Buy | 7,350 | $1.38 |
| Jun 12, 2026 | Geoffrey S Dow | Buy | 7,350 | $1.38 |
| Dec 15, 2025 | Geoffrey S Dow | Buy | 9,670 | $0.80 |
| Dec 15, 2025 | Geoffrey S Dow | Buy | 9,670 | $0.80 |
| Dec 15, 2025 | Geoffrey S Dow | Buy | 9,670 | $0.80 |
| Dec 15, 2025 | Geoffrey S Dow | Buy | 9,670 | $0.80 |
| Dec 11, 2025 | Geoffrey S Dow | Buy | 3,613 | $0.92 |
| Dec 11, 2025 | Geoffrey S Dow | Buy | 3,613 | $0.92 |
| Dec 11, 2025 | Geoffrey S Dow | Buy | 3,613 | $0.92 |
| Dec 11, 2025 | Geoffrey S Dow | Buy | 3,613 | $0.92 |
| Dec 10, 2025 | Geoffrey S Dow | Buy | 9,350 | $0.95 |
| Dec 10, 2025 | Geoffrey S Dow | Buy | 9,350 | $0.95 |
| Dec 10, 2025 | Geoffrey S Dow | Buy | 9,350 | $0.95 |
SXTPW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.01M | $-7.37M | -11.73 | $-6.85M |
| Dec 31, 2024 | $607.57K | $-7.95M | -74.17 | $-5.65M |
| Dec 31, 2023 | $253.57K | $-3.77M | -59.18 | $-4.54M |
| Dec 31, 2022 | $223.21K | $-6.18M | -2.61 | $-1.01M |
Latest balance sheet: total assets $4.28M, total liabilities $1.75M, cash $1.02M (as of Jun 30, 2026).
SXTPW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on SXTPW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.